Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.16 | 0.0002 |
mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0005 |
mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.099 | 0.001 |
mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.003 |